|
|
Volumn 72, Issue 1, 2001, Pages 63-69
|
|
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
ARTICLE;
CADAVER KIDNEY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOSE CALCULATION;
DRUG EFFICACY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
ADRENAL CORTEX HORMONES;
ADULT;
CADAVER;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
GASTROINTESTINAL DISEASES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
SURVIVAL ANALYSIS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 17844397187
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-200107150-00014 Document Type: Article |
|
Times cited : (125)
|
|
References (19)
|
